Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Perinatology|March 15, 2003
Congenital absence of the 5th digital ray and its proximal segmental structuresNeal P Simon, Michael W Simon
Pediatric Emergency Care|October 28, 2003
Cutaneous larva migransMichael W Simon, Neal P Simon
Clinical Pediatrics|October 21, 2004
Changes in newborn bathing practices may increase the risk for omphalitisNeal P Simon, Michael W Simon
Clinical Pediatrics|July 17, 2003
Occurrence of Epstein-Barr virus illness in children diagnosed with group A streptococcal pharyngitisM Carol Rush, Michael W Simon
Drugs in R&D|January 9, 2003
Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illnessMichael W Simon, Douglas N Fish, Robert G Deeter
The Pediatric Infectious Disease Journal|August 28, 2020
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2-9 Years of Age: A Phase III, Randomized StudyCarmen I Baccarini, Michael W Simon, Donald Brandon, et al.
Pediatrics|November 3, 2004
Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and ironRobin K Ohls, Richard A Ehrenkranz, Abhik Das, et al.
Human Vaccines & Immunotherapeutics|March 27, 2020
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized studyGermán Áñez, James Hedrick, Michael W Simon, et al.
The Pediatric Infectious Disease Journal|August 6, 2011
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trialCosette M Wheeler, Bryan M Harvey, Michael E Pichichero, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trialMichael W Simon, Regine Bataille, Nicole S Caldwell, et al.
Pageof 1